Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Comment by LTOWNERon Mar 27, 2012 7:29am
273 Views
Post# 19721594

RE: RE: RE: RE: RE: RE: RE: pick up more today

RE: RE: RE: RE: RE: RE: RE: pick up more today

Thanks for the 2 insider links.

 

Blair appears to have sold 100,000 shares over and above what he pre-announced earlier.  From the information on hand, the extra shares would have come from his Holding company.  I am wondering why there was no pre-announcement of the extra selling.

 

Scotia has held shares since 2002 and only recently, with all the good news and increased liquidity as a result, was there an opportunity for Scotia to take profits.  Until Blair began selling at lower price levels, Scotia selling was quite disciplined, without substantially knocking the price down.  Have to hope Blair is done as he doesn't seem to care about the pressure on the price.  As for Scotia, no way to know how many shares they plan to sell.  The first quarter results should provide some respite for retail investors.

Bullboard Posts